Meiji Yasuda Asset Management Co Ltd. Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

Meiji Yasuda Asset Management Co Ltd. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 36,115 shares of the healthcare conglomerate’s stock after selling 2,641 shares during the period. UnitedHealth Group accounts for about 0.7% of Meiji Yasuda Asset Management Co Ltd.’s portfolio, making the stock its 27th largest position. Meiji Yasuda Asset Management Co Ltd.’s holdings in UnitedHealth Group were worth $18,269,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on UNH shares. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 0.0 %

NYSE UNH opened at $516.94 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a fifty day simple moving average of $509.71 and a two-hundred day simple moving average of $546.15. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market cap of $472.85 billion, a P/E ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.